107 related articles for article (PubMed ID: 19059830)
1. Long-term survivors in stage IV melanoma: a regional population-based study in France.
Tchen T; Léonard F; Derancourt C; Perceau G; Goutorbe C; Reguiaï Z; Bernard P; Grange F
Eur J Dermatol; 2009; 19(1):38-43. PubMed ID: 19059830
[TBL] [Abstract][Full Text] [Related]
2. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
4. [Is surgical therapy of distant metastases of malignant melanoma worthwhile?].
Göhl J; Meyer T; Haas C; Altendorf-Hofmann A; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():122-6. PubMed ID: 9101809
[TBL] [Abstract][Full Text] [Related]
5. Long-term survivor of brain metastases from malignant melanoma.
Mahmood H; Faheem M; Asghar AH; Irfan J
J Coll Physicians Surg Pak; 2010 Dec; 20(12):832-4. PubMed ID: 21205554
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy.
Collinson FJ; Lam TK; Bruijn WM; de Wilt JH; Lamont M; Thompson JF; Kefford RF
Ann Surg Oncol; 2008 Jun; 15(6):1741-9. PubMed ID: 18379853
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival in stage I and stage II malignant melanoma of the limbs--a regional review.
Weaver RM; Grimley RP
Clin Oncol; 1983 Jun; 9(2):131-4. PubMed ID: 6883839
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
[TBL] [Abstract][Full Text] [Related]
9. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
[TBL] [Abstract][Full Text] [Related]
10. Changing biology of cutaneous melanoma.
Peric B; Zgajnar J; Besic N; Hocevar M
Melanoma Res; 2008 Jun; 18(3):225-9. PubMed ID: 18477898
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F
J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436
[TBL] [Abstract][Full Text] [Related]
13. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Gimotty PA; Guerry D; Flaherty K
J Clin Oncol; 2008 Feb; 26(4):517-8. PubMed ID: 18235111
[No Abstract] [Full Text] [Related]
14. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging.
Kimsey TF; Cohen T; Patel A; Busam KJ; Brady MS
Ann Surg Oncol; 2009 May; 16(5):1176-83. PubMed ID: 19224283
[TBL] [Abstract][Full Text] [Related]
15. A rational surgical approach to the treatment of distant melanoma metastases.
Martinez SR; Young SE
Cancer Treat Rev; 2008 Nov; 34(7):614-20. PubMed ID: 18556133
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
Eisen T; Thomas J; Miller WH; Gore M; Wolter P; Kavan P; Martín JA; Lardelli P
Melanoma Res; 2009 Jun; 19(3):185-92. PubMed ID: 19436178
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
18. So-called "malignant blue nevus": a clinicopathologic study of 23 patients.
Martin RC; Murali R; Scolyer RA; Fitzgerald P; Colman MH; Thompson JF
Cancer; 2009 Jul; 115(13):2949-55. PubMed ID: 19472395
[TBL] [Abstract][Full Text] [Related]
19. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
20. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]